Prof. Jan Kyselovic, PharmD, PhD holds professor position of pharmacology and chair of postgraduate PhD course for Pharmacology in Comenius University Bratislava, Slovakia. He is EU expert for EMA and alternant for Commission for Advanced Medicines. He was Research Fellow at Ottawa University, Canada and UCL Brussels, Belgium. He is emeritus dean of Faculty Pharmacy. His innovations in this field led to the receipt of the more than 7 international and 14 domestic grants and he leads a team of 15 scientists (7 PhD students). He has been supervisor theses for more than 150 students and authored/co-authored over 80 peer-reviewed full articles, 2 books co-author, 2 book co-editor and 6 textbooks.
Prof. Kamal Omer Abdalla has earned his PhD in Molecular and Cell Biology from the University of Cape Town, South Africa and master’s diploma in biology-biochemistry from Saint-Petersburg State University, Russia. Currently, he is working as an Associate prof. in the faculties of Medicine and Health Sciences & Medical lab Sciences and Nursing. He holds the director position of Scientific Research and External Relations & Head of Biochemistry Department at the University of Gadarif, Sudan. His research has included investigation of Sudanese natural medicines to treat various chronic human diseases including Diabetes Mellitus and lipid disorders, application of proteomics technology to investigate biomarkers in plant and animal tissues and studying of social and health problems. His contribution in this field led to the receipt of many awards and honors. And he is also serving as editorial and advisory board member of several reputed journals like International Journal of Sudan Research, Merit Research J. of Medicine & Medical Sciences, Journal of Science Reports-Takshila, and University of Gadarif Journal of Science & Humanity. He has authored over 70 research articles and 7 books.
Dr. Jamal Mustafa is a Professor of Physiology and Pharmacology at West Virginia University (WVU). He has awarded with the Dean’s Award for Excellence in Research from SOM in 2008 and became a Robert C. Byrd Professor in 2010. And he also received Chancellor’s Award for Outstanding Achievement in Research and Scholarly Activities from HSC, in 2013. He has published more than 200 manuscripts. His past work has led to the approval of an A2A selective AR agonist (Lexican®) for myocardial perfusion imaging. Currently, they are using AR and β adrenergic receptor KOs to better understand the relationship between these receptors in coronary flow regulation.
Dr. Hany IBRAHIM obtained his master degree, in 2004, from Reims University and his Ph.D., in 2008, from Toulouse University, France. Immediately after, he worked as a researcher at Pharma-Dev laboratory in Toulouse till 2012. In 2013, he worked as consultant in Baxter R&D, Belgium. In 2014, he worked as assistant professor, at the faculty of Pharmacy, Toulouse III University. In 2015, he joined the Egyptian Russian University in Egypt where he serves as the head of Analytical Chemistry Department. Major research points focused on the development of nanoformulation of new drug candidates alongside with the development of new analytical strategies to follow up the drug at different stages during drug discovery (from chemical synthesis to formulation & in vivo post-administration). He had two patents (international & European) and many publications in international journals. He won two French awards, in 2010 “young researcher award” from Foundation for Medical Research and in 2013 “young investigator award” from Toulouse institute of Chemistry.
Harry completed his PhD in Synthetic Organometallic Chemistry at the University of Cape Town in 2010. He joined the Research Centre for Synthesis and Catalysis (Department of Chemistry) at the University of Johannesburg in January 2011 before moving to the Department of Chemical Engineering at the same institution in 2013. In 2015 he joined the Vaal University of Technology RSA after a stint at the National University of Science & Technology in Zimbabwe. His research work entails development of new methodologies for the synthesis of organometallic complexes and their applications in both medicine and catalysis and main interest is on utilizing and developing inorganic chemistry as a tool to answer questions arising in biomedical and biological disciplines. Most recently he has been involved in wastewater treatment and characterisation and synthesis of nanoparticles as potential candidates for a wide range of uses in the chemical industry. Harry has published more than 35 papers in international journals and conference proceedings and is also an active reviewer of accredited scientific journals and external examiner of MSc and PhD theses. He also serves on the Journal Scientific Board of Civil & Environmental Engineers (International Journal of Research in Chemical, Metallurgical and Civil Engineering (IJRCMCE) and is also a Committee member of the Scientific and Technical Committee & Editorial Review Board on Civil and Environmental Engineering (World Academy of Science, Engineering and Technology) WASET.
Dr. Zhang Received B.S. of Pharmaceutical Sciences and M.S. of Pharmacognosy from Peking University, Ph.D. of Oncology in Sun Yat-sen University. He has been a visiting scholar at Hong Kong Baptist University for two years. He is currently Committee Member of the Society of Anti-Cancer Drugs, Chinese Anti-Cancer Association and Committee Member of Division of Tumor Pharmacology, Chinese Pharmacological Society; Council Member of Specialty Committee of Innovation of New Drugs of TCM of World Federation of Chinese Medicine Societies, Council Member of Speciality Committee of TCM Pharmaceutical Chemistry of World Federation of Chinese Medicine Societies.
Hassan was born in 1989 and grows up in Ilam province, where he lives currently. He is currently a research assistant at the medical biology research center (MBRC), Kermanshah University of Medical Science, Kermanshah Iran. After two years from completing his M.Sc. thesis at Razi University (Iran), he spent his time for research on phytochemicals (especially flavonoids and protease inhibitors) working with Professor Reza Khodarahmi, Dr. Hadi Adibi and Dr. Kamran Mansouri. His research interests are in the areas of biological and medicinal chemistry, and structural biology. He also published more than 7 books for Iranian students in the field of bioinformatics and molecular biology. Currently, his major research area is aimed at understanding the molecular mechanisms by which polyphenols (especially flavonoids) can act as potent enzyme inhibitors. He believed that because of their low side-effects and toxicity for human, they can be selected as novel drugs versus pernicious human diseases.
Francesco Maione graduated in Pharmacy in 2005 from the University of Naples Federico II and trained in Pharmacology at the Department of Experimental Pharmacology of the Faculty of Pharmacy. During his PhD in Pharmacology (2005 to 2008) he studied the role of N-formyl-peptides (fMLF and FTM) in different models of pain and inflammation. In these studies Dr. Francesco Maione demonstrated that these endogenous (fMLF) and syntetic peptides (FTM) have a remarkable in vivo inflammatory and painful activity. Dr Maione directed his efforts on this research path even further after beginning his post-doctoral training in the laboratory of Prof. Mauro Perretti and Prof Fulvio D’acquisto, at William Harvey Research Institute - Queen Mary University of London (2008-2010). During this time he expanded, also, his knowledge on inflammation by focusing on immune-mediated inflammatory diseases and investigated the role of Annexin-1 (ANX-1) and interleukin-17A (IL-17A) in different model of inflammation. Since 2010, he joined Prof. Nicola Mascolo’s lab where he re-activated his long-term interest in natural compound biology, starting an unexplored path in the role of natural molecules in the inflammatory response and cardiovascular system. In 2013 Dr Francesco Maione obtained the Specialization in Clinical Pharmacy at University of Naples Federico II and in 2017 the academic position of Assistant Professor in Nutrition Ecology at Department of Pharmacy, School of Medicine, University of Naples Federico II.
Prof. Hadi Adibi received his B.S. degree in chemistry from the Department of Chemistry, Razi University, Kermanshah, Iran, in 1995, M.S. degree in organic chemistry from the Faculty of Sciences, Shiraz University, Shiraz, Iran, in 1998, and Ph.D. degree in organic chemistry from the College of Chemistry, Isfahan University of Technology, Isfahan, Iran, in 2003.Currently he is an Associate Professor at the Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran. Moreover, he has been awarded with the Distinguished Teacher of the Year (May 2005 and May 2006) and Distinguished Researcher of the Year (December 2007, December 2008, December 2010, December 2011, December 2012, December 2013, and December 2014, December 2015). His h-index in accordance with Scopus is 14 and total citations are 742 and published articles are 55.
Dr. Abbas Amini is an assistant professor at Western Sydney University, ACK, and the member of graduate supervisory board. After obtaining PhD, he conducted research with other Australian universities, as a postdoctoral research fellow at Monash and Deakin Universities, and as a senior research fellow at the University of Melbourne. His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas is the editor of ten reputed journals, and the committee member of 20 international conferences.
Jenny Jeehan Nasr is an associate professor of pharmaceutical analytical chemistry in Faculty of Pharmacy, Mansoura University, Egypt. She is a member of the American Chemical Society. She is also a member in the UNESCO Bioethics Network concerned with Women's Issues in the Arab Region. She was a former fellow of L'Oreal-UNESCO for Women in Science Pan Arab Regional Programme. She had achieved her Ph.D. degree in September 2009. Her research focuses on analysis of drugs in formulations and biological fluids in addition to stability studies of drug raw materials. She has prominent contribution in the field of analysis of drug residues in foods in order to serve the community through avoiding risks to human health. Her current research focuses on green chemistry as she tries to find environmentally friendly methods in her developed analytical techniques.